Since the number of Alk1-negative ECs is positively correlated with the AVM severity [18], the introduction of the ALK1 gene to a fraction of ECs of HHT2 patients will be able to reduce AVM severity. The gene discussed is ACVRL1; the disease is telangiectasia, hereditary hemorrhagic, type 2.